NEWT vs CBAN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

NEWT

46.7
AI Score
VS
CBAN Wins

CBAN

51.2
AI Score

Investment Advisor Scores

NEWT

47score
Recommendation
HOLD

CBAN

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NEWT CBAN Winner
Forward P/E 5.3248 11.0011 NEWT
PEG Ratio 3.2026 2.1066 CBAN
Revenue Growth -16.1% 26.0% CBAN
Earnings Growth -49.6% 50.2% CBAN
Tradestie Score 46.7/100 51.2/100 CBAN
Profit Margin 23.7% 24.3% CBAN
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

NEWT 1M: -1.4% · 3M: -19.8% CBAN 1M: +3.0% · 3M: -8.8%

Current Technical Phase

NEWT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.4%), weak momentum, RSI 38

RSI (14): 37.8 · Price: $10.44

CBAN

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -2.6%) with fading momentum, RSI 49

RSI (14): 49.0 · Price: $20.30

Fundamentals Snapshot

Metric NEWT CBAN
Market Cap — —
Forward P/E 5.1 8.5
Trailing P/E 5.7 11.3
Revenue (TTM) — —
Revenue Growth -0.2% 0.3%
Gross Margin 1.0% 1.0%
Operating Margin 0.3% 0.3%
EPS 1.90 1.81
Dividend Yield 0.07% 0.02%

Frequently Asked Questions

Based on our detailed analysis, CBAN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.